APOLIPOPROTEIN-A-I MIMETIKA
European patent · EP2396017 · In force
Register entry
- Publication number
- EP2396017
- Application number
- EP10741801
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 12, 2010
- Published
- Dec 21, 2011
- Granted
- Jul 1, 2015
- Protection ends at the latest
- Feb 11, 2030
- Next annual fee due
- Feb 28, 2027
- IPC classes
- A61K 38/00 (2006.01)//C07K 14/00 (2006.01)//A61K 38/16 (2006.01)
- Priority
- US 152966 P 16.02.2009US 152962 P 16.02.2009US 152960 P 16.02.2009
- PCT application
- PCT/US2010/024096 12.02.2010
- PCT publication
- WO2010/093918 19.08.2010
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 1, 2026
Change
Published in Swissreg on 01.03.2026
- Mar 6, 2025
Change
Published in Swissreg on 06.03.2025
- Mar 1, 2024
Change
Published in Swissreg on 01.03.2024
- Mar 6, 2023
Change
Published in Swissreg on 06.03.2023
- May 25, 2019
Address changed
- Owner
- Cerenis Therapeutics Holding SA, 265 Rue de la Découverte, 31670 Labege, France → CERENIS THERAPEUTICS HOLDING, 33.43 avenue Georges Pompidou, 31130 Balma, France
Published in Swissreg on 25.05.2019
- Sep 11, 2015
Agent entered
- Representative
- ARNOLD & SIEDSMA AG, Baarerstrasse 43, 6300 Zug
Published in Swissreg on 11.09.2015
- Jul 1, 2015
Granted
Published in Swissreg on 01.07.2015
Parties
Inventor
DASSEUX, Jean-louis
F-31300 Toulouse, FR
SCHWENDEMAN, Anna, Shenderova
Superior Township MI 48198, US
ZHU, Lingyu
Shanghai, CN
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.